• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Clin Neuropsychol . Neurocognitive Impairment in Long COVID: A Systematic Review

tetano

Editor, Senior Moderator
Arch Clin Neuropsychol


. 2024 Jun 8:acae042.
doi: 10.1093/arclin/acae042. Online ahead of print. Neurocognitive Impairment in Long COVID: A Systematic Review

Eugenia Panagea[SUP] 1 [/SUP], Lambros Messinis[SUP] 1 2 [/SUP], Maria Christina Petri[SUP] 1 [/SUP], Ioannis Liampas[SUP] 3 [/SUP], Emmanouil Anyfantis[SUP] 4 [/SUP], Grigorios Nasios[SUP] 4 [/SUP], Panayiotis Patrikelis[SUP] 1 [/SUP], Mary Kosmidis[SUP] 1 [/SUP]



Affiliations
Abstract

Objective: Although Coronavirus disease 2019 (COVID-19) is primarily a respiratory infectious disease, it has also been associated with a wide range of other clinical manifestations. It is widely accepted in the scientific community that many patients after recovery continue to experience COVID-19-related symptoms, including cognitive impairment. The aim of this systematic review was to investigate the cognitive profile of patients with long-COVID syndrome.
Methods: A systematic search of empirical studies was conducted through the PubMed/Medline and Scopus electronic databases. Cross-sectional and longitudinal studies published between 2020 and 2023 were included.
Results: Of the 516 studies assessed for eligibility, 36 studies met the inclusion criteria. All included studies support the presence of persistent cognitive changes after COVID-19 disease. Executive function, memory, attention, and processing speed appear to be the cognitive domains that are predominantly associated with long-COVID syndrome, whereas language is an area that has not been sufficiently investigated.
Conclusions: In this review, the high frequency of cognitive impairment after COVID-19 is evident. If we consider that cognitive functioning affects our ability to live independently and is a key determinant of our quality of life, it is imperative to precisely define those factors that may induce cognitive impairment in COVID-19 survivors, with the ultimate goal of early diagnosis of cognitive changes and, consequently, the development of targeted rehabilitation interventions to address them.

Keywords: Language; Long COVID; Neurocognitive impairment.

 
Back
Top Bottom